We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advances in Biomarker Discovery: From Disease Detection to Cure

Biomarkers can reveal a drug’s mechanism of action, early signs of toxicity and which patients are most likely to benefit from treatment.

Article  
Published: December 19, 2024 
Monica Hoyos Flight, PhD
 speaking with 
William C. Cho, PhD , 
Marc Suárez-Calvet, PhD
 & Katerina Akassoglou, PhD
Gloved hand holding a blood sample vial in a laboratory, highlighting biomarker research.
Credit: iStock

Biomarkers offer insights into disease mechanisms, early toxicity signs and patient-specific therapeutic responses. This article explores recent advancements in biomarker discovery across cancer, neurodegenerative and infectious diseases, highlighting the technologies driving these breakthroughs.​


Continue reading to discover how experts in the field are accelerating biomarker identification and paving the way for earlier diagnoses and more precise interventions using cutting-edge tools. 

Sponsored by

Meet the Author
A greyscale headshot of Monica Hoyos Flight
Monica Hoyos Flight, PhD
Freelance Science Writer
Monica is a freelance science communications consultant providing writing and editing services for researchers, research organizations and companies. She has a PhD in neuroscience from Imperial College London and extensive experience as an editor for Springer Nature journals and research communications manager at the University of Edinburgh.
Interviewing
White letters "WCC" on a navy background.
William C. Cho, PhD
Clinical Researcher
William C. Cho is a clinical researcher at Queen Elizabeth Hospital, Hong Kong. His main research interest is the use of high-throughput technologies to discover biomarkers for cancer diagnosis, treatment prediction and prognosis.
White letters "MSC" on a navy background.
Marc Suárez-Calvet, PhD
Clinical Neurologist
Marc Suárez-Calvet is a clinical neurologist and neuroscientist at the BarcelonaBeta Brain Research Center in Spain. His research focuses on understanding the molecular mechanisms of neurodegeneration as well as the discovery of biomarkers in blood and the CSF for neurodegenerative diseases.
White letters "KA" on a navy background.
Katerina Akassoglou, PhD
Professor of Neurology
Professor Katerina Akassoglou is the director of the Gladstone UCSF Center for Neurovascular Brain Immunology. Her research focuses on understanding how neurovascular and neuroimmune mechanisms can contribute to neurological diseases involving CNS autoimmunity and neurodegeneration.
View this Article for FREE Now!
Information you provide will be shared with the sponsors for this content. Technology Networks or its sponsors may contact you to offer you content or products based on your interest in this topic. You may opt-out at any time.
Experiencing issues viewing the form? Click here to access an alternate version
Decoratvive background images
Never miss a story
with the Breaking Science News daily newsletter